German imaging services operator Beyond Imaging (formerly Medneo) is ditching the incumbent European imaging machine suppliers in favour of their Chinese competitor, United Imaging.
Implantable lenses maker STAAR Surgical and Alcon, the world’s largest ophtha device manufacturer, have terminated the merger agreement between them after STAAR failed to get enough of its shareholders to agree to sell. This means STAAR will not be bought out by Alcon and will continue to trade on the NASDAQ stock exchange as its own company.
Carbyne Equity Partners, a German private equity firm, has acquired SuanNutra, a division of the Spanish company Suanfarma that makes and supplies ingredients for the pharmaceutical, veterinary and nutritional sectors. The business was bought from French private equity firm ARCHIMED.
Dutch multinational company Philips has agreed to acquire US medtech firm SpectraWAVE, strengthening its image-guided therapy business and expanding its presence in the coronary intervention segment.
A Philips spokesperson told HBI that the deal aligns with the company’s continued focus on minimally invasive, image-guided therapy.
2025 has been a year of gradual recovery for healthcare investments in Europe, according to Elizabeth Todd, Partner and Co-Lead, European Private Equity Transactions Practice at the global law firm Ropes & Gray.
Ray-Ban maker EssilorLuxottica has agreed to acquire Signifeye, a Belgian ophthalmology network with 15 eye centres and clinics. The acquisition will expand EssilorLuxottica’s eye care presence in Europe.
Tertianum, Switzerland’s largest for-profit nursing home group, is increasing its market share and dominance in the sector by acquiring pan-European French group emeis’ Swiss branch, Senevita, currently the number two. The Swiss competition authority has already given the deal the go-ahead.
2025 has been a strong year overall for healthcare investments. In this interview, HBI speaks to Amit Karna, Partner at Keensight Capital, a European growth buyout investor.
Click here to download your 2025 Christmas Special Deals+Insights briefing The 2025 Christmas bonus special edition covers several major healthcare and life sciences deals: Tertianum, Switzerland’s largest for-profit nursing home group, acquiring Senevita, the Swiss branch of pan-European French group emeis; buyer interest in British supplements company Vitabiotics; London-based private equity firm Bridgepoint’s potential takeover […]
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
